Current and former chairs of cardiology at Cedars-Sinai to be honored by peers in Chicago

April 01, 2003

LOS ANGELES (EMBARGOED UNTIL APRIL 1, 2003 AT 6 P.M. CST) - P.K. Shah, M.D., director of the division of cardiology at Cedars-Sinai Medical Center since 1995, will receive two awards while he is in Chicago to attend the annual scientific session of the American College of Cardiology, taking place March 30 to April 2.

In addition, H.J.C. Swan, M.D., chairman emeritus of cardiology at Cedars-Sinai, who steered the program in earlier years of growth and organization, will receive the ACC's "Distinguished Scientific Achievement Award."

Dr. Swan and colleague William Ganz, M.D., introduced the Swan-Ganz heart catheter into clinical practice in 1970, triggering a critical-care revolution in the management of critically ill patients. Dr. Swan served as Chairman of Cardiology from 1965 to 1987.

Dr. Shah, director of the Division of Cardiology, director of the Atherosclerosis Research Center, holder of the Shapell and Webb Family Endowed Chair in Cardiology at Cedars Sinai Medical Center, and professor of medicine at the David Geffen School of Medicine at the University of California, Los Angeles, will receive the ACC's "Gifted Teacher Award." It will be presented during the ACC's Convocation Ceremony on Tuesday, April 1, at the Chicago Hilton.

On Saturday, March 29, Dr. Shah will receive the "Vulnerable Plaque Lifetime Achievement Award" from the Association for Eradication of Heart Attack (AEHA), a non-profit organization that promotes education and research related to mechanism, prevention, detection, and treatment of coronary heart disease. AEHA, based at the Texas Medical Center in Houston, will present the award to recognize Dr. Shah's pioneering research, contributions and discoveries.

Especially since the Atherosclerosis Research Center was founded in 1993, Dr. Shah has focused a great deal of research attention on the basic mechanisms that contribute to plaque and clot build-up inside arteries, exploring innovative ways to prevent and reverse the process. These novel approaches include the exploration of gene therapy and the development of an immunization strategy.

In 1982, five years after joining the medical center as a staff cardiologist, Dr. Shah, collaborating with Dr. Ganz, provided the first clot-dissolving therapy to treat heart attacks in human subjects, a treatment that soon became the standard worldwide. He was named director of the medical center's Cardiovascular Fellowship Training Program in 1988 and two years later was awarded the cardiology chair.

Dr. Shah is highly regarded by his peers as an excellent scientific investigator, a compassionate clinician and a skilled educator. He has been a Fulbright Visiting Professor internationally and has served as a visiting professor at such prestigious national institutions as Harvard Medical School, Mayo Clinic, Cleveland Clinic, Texas Heart Institute, the University of Virginia, Charlottesville, and the University of Utah Medical Center, Salt Lake City.

"It's a great honor to receive these awards from the Association for Eradication of Heart Attack and the American College of Cardiology ," said Dr. Shah. "Since the inception of the cardiology program, Cedars-Sinai has encouraged the sharing of information, the education of new generations, and the pursuit of scientific and technological innovations in diagnosis, care and prevention. Dr. Swan deserves a great deal of credit for taking these commitments to an even higher level. His are not easy footsteps to follow, and I'm very pleased that the ACC is recognizing his scientific achievements."
-end-


Cedars-Sinai Medical Center

Related Heart Attack Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Molecular imaging identifies link between heart and kidney inflammation after heart attack
Whole body positron emission tomography (PET) has, for the first time, illustrated the existence of inter-organ communication between the heart and kidneys via the immune system following acute myocardial infarction.

Muscle protein abundant in the heart plays key role in blood clotting during heart attack
A prevalent heart protein known as cardiac myosin, which is released into the body when a person suffers a heart attack, can cause blood to thicken or clot--worsening damage to heart tissue, a new study shows.

New target identified for repairing the heart after heart attack
An immune cell is shown for the first time to be involved in creating the scar that repairs the heart after damage.

Heart cells respond to heart attack and increase the chance of survival
The heart of humans and mice does not completely recover after a heart attack.

A simple method to improve heart-attack repair using stem cell-derived heart muscle cells
The heart cannot regenerate muscle after a heart attack, and this can lead to lethal heart failure.

Mount Sinai discovers placental stem cells that can regenerate heart after heart attack
Study identifies new stem cell type that can significantly improve cardiac function.

Fixing a broken heart: Exploring new ways to heal damage after a heart attack
The days immediately following a heart attack are critical for survivors' longevity and long-term healing of tissue.

Heart patch could limit muscle damage in heart attack aftermath
Guided by computer simulations, an international team of researchers has developed an adhesive patch that can provide support for damaged heart tissue, potentially reducing the stretching of heart muscle that's common after a heart attack.

How the heart sends an SOS signal to bone marrow cells after a heart attack
Exosomes are key to the SOS signal that the heart muscle sends out after a heart attack.

Read More: Heart Attack News and Heart Attack Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.